Impact of the Duration of Controlled Ovarian Stimulation on Assisted Reproduction Cycle Outcomes

Objective: To investigate the impact of duration of controlled ovarian stimulation on vitro fertilization outcomes.Study Design: Medical records of 3194 IVF and ICSI cycles from the assisted reproduction unit of a tertiary hospital were retrospectively analyzed using a computer based database. Characteristics of cycles with duration of stimulation ≤ 8 days (group I), 9 to 12 days (group II) or ≥13 days (group III) were studied retrospectively. Subgroup analysis was also done for poor responders, patients with polycystic ovary syndrome and normoresponders.Results: Estradiol on trigger day, number of retrieved oocytes, mature oocytes and fertilized oocytes were significantly higher in group II compared to the other two groups when all cycles were analyzed (p<0.001). No significant difference was observed regarding clinical and ongoing pregnancy rates between groups. Regarding poor responders, the number of mature oocytes and the number of fertilized oocytes were higher in group II compared to the other groups (p=0.028, p=0.038, respectively). Ongoing pregnancy rates were significantly lower in group III compared to other groups (p= 0.041). In patients with polycystic ovary syndrome, number of retrieved oocytes was significantly lower in group III compared to group II (p=0.047) and number of mature oocytes was significantly lower in group III compared to the other groups (p=0.005). No significant difference was found in the clinical and ongoing pregnancy rates. Number of retrieved oocytes, clinical and ongoing pregnancy rates were comparable between three groups for normoresponders.Conclusion: Prolonged cycles have a detrimental effect only on ongoing pregnancy rates in poor responders.

[1]  G. Emerson,et al.  The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles , 2017, Irish Journal of Medical Science (1971 -).

[2]  Z. Rosenwaks,et al.  Prolonged gonadotropin stimulation in fresh in vitro fertilization cycles and its impact on pregnancy outcomes , 2015 .

[3]  A. Setti,et al.  The Impact of Pituitary Blockage with GnRH Antagonist and Gonadotrophin Stimulation Length on The Outcome of ICSI Cycles in Women Older than 36 Years , 2014, International journal of fertility & sterility.

[4]  Shunping Wang,et al.  Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome , 2014, Journal of Assisted Reproduction and Genetics.

[5]  B. Fauser,et al.  Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective analysis of the Engage trial. , 2014, Reproductive biomedicine online.

[6]  R. Robinson,et al.  Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates. , 2012, The Journal of reproductive medicine.

[7]  L. Hyun,et al.  Does the Ovarian Stimulation Phase Length Predict In vitro Fertilization Outcomes , 2011 .

[8]  L. Gianaroli,et al.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. , 2011, Human reproduction.

[9]  G. Neal-Perry,et al.  Prolonged gonadotropin stimulation is associated with decreased ART success , 2010, Journal of Assisted Reproduction and Genetics.

[10]  R. Orvieto,et al.  Controlled ovarian hyperstimulation: Does prolonged stimulation justify cancellation of in vitro fertilization cycles? , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[11]  S. Franks,et al.  Fertilization and early embryology: Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries , 1995 .

[12]  Denny Sakkas,et al.  Impact of duration and dose of gonadotrophins on IVF outcomes. , 2006, Reproductive biomedicine online.

[13]  M. Eijkemans,et al.  A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. , 2006, Human reproduction update.

[14]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.